City National Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

City National Bank’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$177K	Sell	30,280 -284,352	-90%	-$2.19M	﹤0.01%	783
2015 Q2	$2.6M	Sell	314,632 -619,420	-66%	-$5.48M	0.02%	345
2015 Q1	$7.7M	Buy	934,052 +213,267	+30%	+$1.58M	0.06%	239
2014 Q4	$4.95M	Buy	720,785 +61,919	+9%	+$387K	0.04%	281
2014 Q3	$3.56M	Buy	658,866 +34,136	+5%	+$199K	0.03%	295
2014 Q2	$3.98M	Buy	624,730 +323,294	+107%	+$2.22M	0.04%	291
2014 Q1	$2.43M	Buy	301,436 +107,235	+55%	+$835K	0.03%	281
2013 Q4	$1.32M	Buy	194,201 +154,729	+392%	+$835K	0.02%	372
2013 Q3	$726K	Sell	39,472 -1,235	-3%	-$24K	0.01%	451
2013 Q2	$712K	Buy	+40,707	New	+$722K	0.01%	465

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

City National Bank's ARIA Position: Q3 2015 in Review

City National Bank reduced its Ariad Pharmaceuticals Inc (ARIA) stake by 90% in Q3 2015, selling an estimated $2.19M and leaving 30,280 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

City National Bank first reported a position in ARIA in Q2 2013 and has held it in 10 quarters since. The position peaked at $7.7M in Q1 2015. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

City National Bank held 30,280 shares of Ariad Pharmaceuticals Inc worth $177K as of Q3 2015.
City National Bank sold 284,352 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $2.19M.
Ariad Pharmaceuticals Inc made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #783 holding.
City National Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 10 quarters since.
City National Bank's Ariad Pharmaceuticals Inc position peaked at $7.7M in Q1 2015.
175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.